Drug repurposing and discovery represent a transformative approach in modern pharmacology, seeking to identify new therapeutic uses for existing, approved compounds while also uncovering novel drug ...
Move over, Hugh Laurie: there’s a new Dr. House in town. Harvard Medical School associate professor Marinka Zitnik and her lab announced the development of TxGNN, an artificial intelligence model ...
A global expert review has identified a shingles vaccine and two existing drugs as leading candidates for repurposing against ...
One person's side effect could be another person's treatment if we expand our perspective on small molecule drug targets, according to a new study published November 5, 2025, in npj Precision Oncology ...
Findacure, a rare diseases charity based in Cambridge, says repurposing existing drugs to treat rare diseases will improve patient outcomes and save the NHS money. Diseases that affect less than 1 in ...
HERSHEY, Pa. — Americans pay a lot of money for prescription medications. In 2023, spending on prescription drugs in the United Stated topped $722 billion, a trend that’s expected to continue. Yet, ...
Researchers used RBF4, a compound chemically identical to an FDA-approved heart medication, to target lymphoma. In ...
Predictive Oncology Inc. has updated shareholders on its advancements in AI-driven drug discovery, specifically in biomarker discovery and drug repurposing, amid a growing biomarker discovery market ...
Scientists from Harvard Medical School are using artificial intelligence (AI) to solve the problem of finding treatments for rare and neglected diseases. They have developed a new method, called TxGNN ...
One person's side effect could be another person's treatment if we expand our perspective on small molecule drug targets, according to a new study published November 5, 2025, in npj Precision Oncology ...
What do medical researchers do all day? Until recently, some of them arduously and meticulously tried to match drug molecules with potential diseases they could help alleviate. But after long and ...